Aerie Pharmaceuticals Inc (AERI)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4301 EMPEROR BOULEVARD DURHAM, NC 27703

Aerie Pharmaceuticals, Inc. operates a clinical stage pharmaceutical company. The company focuses on the discovery, development, and distribution of pharmaceutical products for the treatment of glaucoma and other disease of the eye. Aerie Pharmaceuticals offers its products to the medical industry.

Data based on most recent fiscal year report
Market Cap1.045 Billion Shares Outstanding46.32 Million Avg Volume1.184 Million
1-Yr BETA vs S&P TR1.05 Current Ratio4.34 Quick Ratio4.14
View SEC Filings from AERI instead.

View recent insider trading info

Funds Holding AERI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AERI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1 Million total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCHUGH JULIE

  • Director
23,849 2020-03-03 1

MEHRA ANAND

  • Director
8,876 2020-03-02 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL FUND III, L.P.

FORESITE CAPITAL FUND IV, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL MANAGEMENT IV, LLC

TANANBAUM JAMES B.

  • 10% Owner
4,524,591 2020-02-27 6

ANIDO VICENTE JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
230,296 2020-02-23 7

KOPCZYNSKI CASEY C. CHIEF SCIENTIFIC OFFICER

  • Officer
226,114 2020-02-23 4

MITRO THOMAS A PRESIDENT AND COO

  • Officer
79,569 2020-02-23 5

RUBINO RICHARD J CHIEF FINANCIAL OFFICER

  • Officer
347,851 2020-02-23 6

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
6,621,485 2020-02-21 0

LAROCCA JOHN GENERAL COUNSEL

  • Officer
32,723 2020-02-19 4

FORESITE CAPITAL MANAGEMENT IV, LLC

FORESITE CAPITAL FUND IV, L.P.

TANANBAUM JAMES B.

  • 10% Owner
5,524,591 2019-12-20 4

HOLLANDER DAVID CHIEF R&D OFFICER

  • Officer
0 2019-11-11 2

DUYK GEOFFREY M

  • Director
13,832 2019-10-23 0

GRYSKA DAVID W

  • Director
48,013 2019-10-01 1

CROARKIN RICHARD

  • Director
0 2019-06-20 1

GOLDBERG MURRAY A

  • Director
0 2019-06-11 1

MCGRAW BENJAMIN F III

  • Director
8,050 2019-05-23 1

CAGLE GERALD D.

  • Director
21,550 2019-05-23 1

DU TOIT MICHAEL

  • Director
6,350 2019-05-23 1

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
5,853,502 2018-07-23 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
3,643,191 2017-05-26 0

LEVY BRIAN

  • Director
No longer subject to file 2016-02-10 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
No longer subject to file 2016-02-08 0

ACP IV, L.P.

JANNEY DANIEL

NOHRA GUY P

ACMP IV LLC

  • 10% Owner
No longer subject to file 2014-07-16 0

SOFINNOVA VENTURE PARTNERS VII L P

SOFINNOVA MANAGEMENT VII, L.L.C.

HEALY JAMES

BUATOIS ERIC

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2014-07-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FORESITE CAPITAL MANAGEMENT II, LLC - > 10% Owner see footnote

FORESITE CAPITAL FUND II, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND III, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND IV, L.P. - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT III, LLC - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT IV, LLC - > 10% Owner see footnote

TANANBAUM JAMES B. - > 10% Owner see footnote

2020-02-27 S 425,457 $17.07 d 1,925,020 4,524,591.00 indirect

FORESITE CAPITAL MANAGEMENT II, LLC - > 10% Owner see footnote

FORESITE CAPITAL FUND II, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND III, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND IV, L.P. - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT III, LLC - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT IV, LLC - > 10% Owner see footnote

TANANBAUM JAMES B. - > 10% Owner see footnote

2020-02-27 S 302,776 $17.07 d 1,369,938 4,524,591.00 indirect

FORESITE CAPITAL MANAGEMENT II, LLC - > 10% Owner see footnote

FORESITE CAPITAL FUND II, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND III, L.P. - > 10% Owner see footnote

FORESITE CAPITAL FUND IV, L.P. - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT III, LLC - > 10% Owner see footnote

FORESITE CAPITAL MANAGEMENT IV, LLC - > 10% Owner see footnote

TANANBAUM JAMES B. - > 10% Owner see footnote

2020-02-27 S 271,767 $17.07 d 1,229,633 4,524,591.00 indirect

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-24 F 669 $20.30 d 226,114 226,114.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-24 F 1,027 $20.30 d 79,569 79,569.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-24 F 857 $20.30 d 347,851 347,851.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-24 F 1,527 $20.30 d 219,796 230,296.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-23 F 410 $21.59 d 348,708 347,851.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-23 F 1,052 $21.59 d 221,323 230,296.00 direct

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-23 F 328 $21.59 d 226,783 226,114.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-23 F 763 $21.59 d 80,596 79,569.00 direct

LAROCCA JOHN - Officer GENERAL COUNSEL

2020-02-19 F 1,542 $19.47 d 32,723 32,723.00 direct

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-08 F 700 $20.49 d 227,111 227,111.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-08 F 1,183 $20.49 d 81,359 81,359.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-08 F 1,546 $20.49 d 222,375 232,875.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-08 F 1,023 $20.49 d 349,118 349,118.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-07 F 1,055 $20.49 d 350,141 349,118.00 direct

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-07 F 700 $20.49 d 227,811 227,111.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-07 F 1,307 $20.49 d 82,542 81,359.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-07 F 1,710 $20.49 d 223,921 232,875.00 direct

LAROCCA JOHN - Officer GENERAL COUNSEL

2020-02-07 F 693 $20.49 d 34,265 34,265.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-06 A 14,000 a 83,849 83,849.00 direct

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-06 A 10,000 a 228,511 228,511.00 direct

LAROCCA JOHN - Officer GENERAL COUNSEL

2020-02-06 A 15,500 a 15,500 34,958.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-06 A 28,000 a 225,631 236,131.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-06 A 52,000 a 52,000 351,196.00 direct

LAROCCA JOHN - Officer GENERAL COUNSEL

2020-02-06 A 3,500 a 34,958 34,958.00 direct

MITRO THOMAS A - Officer PRESIDENT AND COO

2020-02-06 A 62,500 a 62,500 83,849.00 direct

KOPCZYNSKI CASEY C. - Officer CHIEF SCIENTIFIC OFFICER

2020-02-06 A 45,000 a 45,000 228,511.00 direct

RUBINO RICHARD J - Officer CHIEF FINANCIAL OFFICER

2020-02-06 A 11,750 a 351,196 351,196.00 direct

ANIDO VICENTE JR - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-06 A 125,000 a 125,000 236,131.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.69% 2016-01-11 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.59% 2016-02-18 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.8% 2015-10-26 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc. 0.7% 2015-10-21 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc. 0.51% 2015-10-16 GERMANY
HBK Investments L.P. Aerie Pharmaceuticals Inc 0.79% 2015-12-07 GERMANY

Elevate your investments